Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: A multicenter study

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 451-458

  Kuptniratsaikul, Vilai ^a   Dajpratham, Piyapat ^a   Taechaarpornkul, Wirat ^b   Buntragulpoontawee, Montana ^c   Lukkanapichonchut, Pranee ^d   Chootip, Chirawan ^e   Saengsuwan, Jittima ^f   Tantayakom, Kesthamrong ^g   Laongpech, Supphalak ^h  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d Ratchaburi Regional Hospital   (Thailand)

^e Songkhla Hospital   (Thailand)

^f KHON KAEN UNIVERSITY   (Thailand)

^g RAJAVITHI HOSPITAL   (Thailand)

^h Vachira Phuket Hospital   (Thailand)

Author keywords

Curcuma domestica; Curcumin; Effcacy; Ibuprofen; Knee osteoarthritis; Safety

Indexed keywords

ANALGESIC AGENT; CURCUMA DOMESTICA EXTRACT; IBUPROFEN; PLANT EXTRACT; TRAMADOL; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CURCUMA LONGA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EDEMA; FEMALE; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MELENA; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; CLINICAL TRIAL; COMPARATIVE STUDY; CURCUMA; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PHYTOTHERAPY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CURCUMA; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84897826213     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s58535     Document Type: Article

References (39)

1. Fransen M, Bridgett L, March L, Hoy D, Penserga E, Brooks P. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis. 2011;14(2): 113-121.
2. Kim IJ, Kim HA, Seo YI, et al. Prevalence of knee pain and its influ-ence on quality of life and physical function in the Korean elderly population: a community based cross-sectional study. J Korean Med Sci. 2011;26(9):1140-1146.
3. March LM, Bagga H. Epidemiology of osteoarthritis in Australia. Med J Aust. 2004;180(Suppl 5):S6-S10.
4. Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM R. 2012;4(Suppl 5):S10-S19.
5. Du H, Chen SL, Bao CD, et al. Prevalence and risk factors of knee osteoarthritis in Huang-Pu District, Shanghai, China. Rheumatol Int. 2005;25(8):585-590.
6. Yoshida S, Aoyagi K, Felson DT, Aliabadi P, Shindo H, Takemoto T. Comparison of the prevalence of radiographic osteoarthritis of the knee and hand between Japan and the United States. J Rheumatol. 2002;29(7): 1454-1458.
7. Cho HJ, Chang CB, Kim KW, et al. Gender and prevalence of knee osteoarthritis types in elderly Koreans. J Arthroplasty. 2011;26(7): 994-999.
8. Kuptniratsaikul V, Tosayanonda O, Nilkanuwong S, Thamlikitkul V. The epidemiology of knee osteoarthritis patients. J Med Assoc Thai. 2002;85(2):154-161.
9. Seed SM, Dunican KC, Lynch AM. Osteoarthritis: a review of treatment options. Geriatrics. 2009;64(10):20-29.
10. Gumbrevicius G, Milasius A, Sveikata A. Nonsteroidal anti- inflammatory agents: choice between disturbances of gastrointestinal tract and cardiovascular toxicity. Medicina (Kaunas). 2006;42(5):429-439.
11. Gallelli L, Colosimo M, Pirritano D, et al. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig. 2007;27(2):115-122.
12. Turajane T, Wongbunnak R, Patcharatrakul T, Ratansumawong K, Poigampetch Y, Songpatanasilp T. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. J Med Assoc Thai. 2009;92(Suppl 6): S19-S26.
13. Bengmark S. Curcumin, an atoxic antioxidant and natural NF kappa B, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. J Parenter Enteral Nutr. 2006;30(1):45-51.
14. Oyagbemi AA, Saba AB, Ibraheem AO. Curcumin: from food spice to cancer prevention. Asian Pac J Cancer Prev. 2009;10(6):963-967.
15. Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007;7(3):344-351.
16. Saja K, Babu MS, Karunagaran D, Sudhakaran PR. Anti-infammatory effect of curcumin involves downregulation of MMP-9 in blood mono-nuclear cells. Int Immunopharmacol. 2007;7(13):1659-1667.
17. Kim KH, Lee EN, Park JK, et al. Curcumin attenuates TNF-α-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytother Res. 2012;26(7):1037-1047.
18. Yang Q, Wu S, Mao X, Wang W, Tai H. Inhibition effect of curcumin on TNF-α and MMP-13 expression induced by advanced glycation end products in chondrocytes. Pharmacology. 2013;91(1-2): 77-85.
19. Jackson JK, Higo T, Hunter WL, Burt HM. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Infam Res. 2006;55(4):168-175.
20. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumuric (Curcuma longa). J Altern Complement Med. 2003;9(1):161-168.
21. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-2900.
22. Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, Wattanamongkonsil L, Thamlikitkul V. Effcacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Comple Med. 2009;15(8):891-897.
23. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-1049.
24. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502.
25. Kuptniratsaikul V, Rattanachaiyanont M. Validation of a modifled Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis. Clin Rheumatol. 2007;26(10): 1641-1645.
26. Hauck WW, Anderson S. Some issues in the design and analysis of equivalence trials. Drug Inf J. 1999;33:109-118.
27. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol. 2003;25(2):213-224.
28. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res. 2005;2(2):131-136.
29. Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010;17(3):190-197.
30. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007;255(2):170-181.
31. Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. 2005;5(2):117-129.
32. Henrotin Y, Clutterbuck AL, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 2010;18(2):141-149.
33. Lev-Ari S, Strier L, Kazanov D, et al. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford). 2006;45(2):171-177.
34. Belcaro G, Cesarone MR, Dugall M, et al. Effcacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010;15(4):337-344.
35. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol. 2004;10(5):236-245.
36. Pinsornsak P, Niempoog S. The effcacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012;95(Suppl 1):S51-S58.
37. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96.
38. Gallelli L, Galasso O, Urzino A, et al. Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis. Clin Drug Investig. 2012;32(12):827-833.
39. Gallelli L, Galasso O, Falcone D, et al. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthritis Cartilage. 2013;21(9): 1400-1408.